Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zi Han Loh, Huey Chong Kwong, Kok Wai Lam, Soek Sin Teh, Gwendoline Cheng Lian Ee, Ching Kheng Quah, Anthony Siong Hock Ho & Siau Hui Mah. (2021) New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 627-639.
Read now
Read now
Rohit Sharma, Kamil Kuca, Eugenie Nepovimova, Atul Kabra, MM Rao & PK Prajapati. (2019) Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside. Expert Review of Neurotherapeutics 19:5, pages 359-374.
Read now
Read now
Arif Nisha Syad & Kasi Pandima Devi. (2014) Botanics: a potential source of new therapies for Alzheimer's disease?. Botanics: Targets and Therapy 4, pages 11-26.
Read now
Read now
Mohammad Fazil, Shadab, Sanjula Baboota, Jasjeet K. Sahni & Javed Ali. (2012) Nanotherapeutics for Alzheimer’s disease (AD): Past, present and future. Journal of Drug Targeting 20:2, pages 97-113.
Read now
Read now
Articles from other publishers (42)
Riya Joshi, Hemi Missong, Jayapriya Mishra, Satinder Kaur, Sumant Saini, Ramesh Kandimalla, P. Hemachandra Reddy, Arockia Babu, Gurjit Kaur Bhatti & Jasvinder Singh Bhatti. (2023) Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies. Journal of Drug Delivery Science and Technology 89, pages 105067.
Crossref
Crossref
Mubashir Hassan, Saba Shahzadi, Muhammad Yasir, Wanjoo Chun & Andrzej Kloczkowski. (2023) Computational prognostic evaluation of Alzheimer’s drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches. Scientific Reports 13:1.
Crossref
Crossref
Ashvin VaradharajanAarjith Damian DavisAishwarya GhoshTejaswini JagtapAnjo XavierAnjana Jayakumar MenonDwaiti RoySandhya GandhiThomas Gregor. (2023) Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs. Journal of Neurosciences in Rural Practice 14, pages 566-573.
Crossref
Crossref
Sonal Dubey & Ekta Singh. (2023) Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease. Inflammopharmacology 31:2, pages 717-730.
Crossref
Crossref
Prashanth Punyakoti, Tapan Behl, Aayush Sehgal, Shivam Yadav, Monika Sachdeva, Md. Khalid Anwer, Celia Vargas-De-La-Cruz, Thangavel Venkatachalam, Maaz Naqvi, Raman Verma & Hardeep Singh Tuli. (2023) Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease. Cellular Signalling 102, pages 110539.
Crossref
Crossref
Marina Silalahi, Endang C. Purba, I. Gusti Ayu Rai Sawitri, Anisatu Z. Wakhidah & Eny Yuniati. 2023. Medicinal Plants: Biodiversity, Biotechnology and Conservation. Medicinal Plants: Biodiversity, Biotechnology and Conservation
289
306
.
Mubashir Hassan, Saba Shahzadi & Andrzej Kloczkowski. 2023. Bioinformatics and Biomedical Engineering. Bioinformatics and Biomedical Engineering
191
201
.
Ioanna-Chrysoula Tsopka & Dimitra Hadjipavlou-Litina. 2023. Computational Modeling of Drugs Against Alzheimer’s Disease. Computational Modeling of Drugs Against Alzheimer’s Disease
355
381
.
Çağla Begüm Apaydın, Özge Soylu-Eter, Pınar Eraslan-Elma, Nurten Özsoy & Nilgün Karalı. (2022) Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future Medicinal Chemistry 14:23, pages 1705-1723.
Crossref
Crossref
Rouchan Ali, Ghanshyam Das Gupta & Pooja A. Chawla. (2022) Aducanumab: A new hope in Alzheimer's disease. Health Sciences Review 4, pages 100039.
Crossref
Crossref
Nasser A. Hassan, Asma K. Alshamari, Allam A. Hassan, Mohamed G. Elharrif, Abdullah M. Alhajri, Mohammed Sattam & Reham R. Khattab. (2022) Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology. Molecules 27:15, pages 4839.
Crossref
Crossref
Manoj Koirala, Vahid Karimzadegan, Nuwan Sameera Liyanage, Natacha Mérindol & Isabel Desgagné-Penix. (2022) Biotechnological Approaches to Optimize the Production of Amaryllidaceae Alkaloids. Biomolecules 12:7, pages 893.
Crossref
Crossref
Bhuvaneswari Sivaraman, Vijaykumar Raji, Bala Aakash Velmurugan & Ramalakshmi Natarajan. (2022) Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential
for Alzheimer's Disease. CNS & Neurological Disorders - Drug Targets 21:5, pages 427-449.
Crossref
Crossref
Raluca Ioana Teleanu, Manuela Daniela Preda, Adelina-Gabriela Niculescu, Oana Vladâcenco, Crina Ioana Radu, Alexandru Mihai Grumezescu & Daniel Mihai Teleanu. (2022) Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier. Pharmaceutics 14:5, pages 987.
Crossref
Crossref
Rajeev Taliyan, Violina Kakoty, K.C. Sarathlal, Sanskruti Santosh Kharavtekar, Chandrashekar R. Karennanavar, Yogendra Kumar Choudhary, Gautam Singhvi, Yassine Riadi, Sunil Kumar Dubey & Prashant Kesharwani. (2022) Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease. Journal of Controlled Release 343, pages 528-550.
Crossref
Crossref
Daniel Pardo-Rodriguez, Paola Lasso, José Mateus, John Mendez, Concepción J. Puerta, Adriana Cuéllar, Jorge Robles & Claudia Cuervo. (2022) A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cruzi activity and induces T cell cytokine production. Heliyon 8:3, pages e09182.
Crossref
Crossref
Andrila E. Collins, Tarek M. Saleh & Bettina E. Kalisch. (2022) Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease. Antioxidants 11:2, pages 213.
Crossref
Crossref
Asim Najmi, Sadique A. Javed, Mohammed Al Bratty & Hassan A. Alhazmi. (2022) Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents. Molecules 27:2, pages 349.
Crossref
Crossref
Gustavo Alves Andrade dos Santos, Carolina Witchmichen Penteado Schmidt & Karina Pedrotti Forlenza. 2022. Pharmacological Treatment of Alzheimer's Disease. Pharmacological Treatment of Alzheimer's Disease
53
68
.
Edward D. Hall, Eugene Park & Andrew J. Baker. 2022. Tackling the Concussion Epidemic. Tackling the Concussion Epidemic
181
207
.
Kavita Sharma, Samjhana Pradhan, Lawrence K. Duffy, Sabina Yeasmin, Nirajan Bhattarai & Marvin K. Schulte. (2021) Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology. International Journal of Molecular Sciences 22:23, pages 12987.
Crossref
Crossref
Nikolay Vasilev. (2021) Medicinal Plants: Guests and Hosts in the Heterologous Expression of High-Value Products. Planta Medica.
Crossref
Crossref
Mohd Shahnawaz Khan, Fohad Mabood Husain, Fahad A. Alhumaydhi, Ameen S.S. Alwashmi, Md. Tabish Rehman, Abdulmohsen M. Alruwetei, Md. Imtaiyaz Hassan, Asimul Islam & Anas Shamsi. (2021) Exploring the molecular interactions of Galantamine with human Transferrin: In-silico and in vitro insight. Journal of Molecular Liquids 335, pages 116227.
Crossref
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Crossref
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Crossref
Roma Ghai, Kandasamy Nagarajan, Meenakshi Arora, Parul Grover, Nazakat Ali & Garima Kapoor. (2020) Current Strategies and Novel Drug Approaches for Alzheimer Disease. CNS & Neurological Disorders - Drug Targets 19:9, pages 676-690.
Crossref
Crossref
A.A.D.T. Abeysinghe, R.D.U.S. Deshapriya & C. Udawatte. (2020) Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions. Life Sciences 256, pages 117996.
Crossref
Crossref
Riccardo Trentin, Luísa Custódio, Maria João Rodrigues, Emanuela Moschin, Katia Sciuto, José Paulo da Silva & Isabella Moro. (2020) Exploring Ulva australis Areschoug for possible biotechnological applications: In vitro antioxidant and enzymatic inhibitory properties, and fatty acids contents. Algal Research 50, pages 101980.
Crossref
Crossref
Viana Castañeda-Loaiza, Chloé Placines, Maria João Rodrigues, Catarina Pereira, Gokhan Zengin, Ahmet Uysal, József Jeko, Zoltán Cziáky, Catarina Pinto Reis, Maria Manuela Gaspar & Luísa Custódio. (2020) If you cannot beat them, join them: Exploring the fruits of the invasive species Carpobrotus edulis (L.) N.E. Br as a source of bioactive products. Industrial Crops and Products 144, pages 112005.
Crossref
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration
325
357
.
Onnita Thancharoen, Chulaporn Limwattananon, Onanong Waleekhachonloet, Thananan Rattanachotphanit, Phumtham Limwattananon & Panita Limpawattana. (2019) Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer’s Disease: A Network Meta-Analysis. Drugs & Aging 36:5, pages 435-452.
Crossref
Crossref
Johanna Michael, Julia Marschallinger & Ludwig Aigner. (2019) The leukotriene signaling pathway: a druggable target in Alzheimer’s disease. Drug Discovery Today 24:2, pages 505-516.
Crossref
Crossref
Yingbo Shi, Qiaoling Wang & Shuanhu Gao. (2018) Recent advances in the intramolecular Mannich reaction in natural products total synthesis. Organic Chemistry Frontiers 5:6, pages 1049-1066.
Crossref
Crossref
Lise Aagaard. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
1
25
.
Krista Lanctôt, Ida Kircanski, Sarah Chau & Nathan Herrmann. 2012. Alzheimer's Disease. Alzheimer's Disease
117
161
.
Nathan Herrmann, Sarah A. Chau, Ida Kircanski & Krista L. Lanctôt. (2011) Current and Emerging Drug Treatment Options for Alzheimerʼs Disease. Drugs 71:15, pages 2031-2065.
Crossref
Crossref
Zhong Yang, Yingge Zhang, Yanlian Yang, Lan Sun, Dong Han, Hong Li & Chen Wang. (2010) Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine: Nanotechnology, Biology and Medicine 6:3, pages 427-441.
Crossref
Crossref
Peter Dome, Judit Lazary, Miklos Peter Kalapos & Zoltan Rihmer. (2010) Smoking, nicotine and neuropsychiatric disorders. Neuroscience & Biobehavioral Reviews 34:3, pages 295-342.
Crossref
Crossref
Deanna M. Barch. 2010. Behavioral Neurobiology of Schizophrenia and Its Treatment. Behavioral Neurobiology of Schizophrenia and Its Treatment
43
96
.
Bernadette McGuinnessDavid Wilson, Stephen Todd & Peter Passmore. (2009) Effective use of drugs in Alzheimer's disease. Practice Nursing 20:Sup1, pages S11-S14.
Crossref
Crossref
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances
712
715
.
Daniel Pardo-Rodriguez, Paola Lasso, Jose Mateus, Jonh Jairo Mendez Arteaga, Concepción J. Puerta, Adriana Cuéllar, Jorge Robles & Claudia L. Cuervo. (2021) A Terpenoid-Rich Extract from <i>Clethra Fimbriata</i> Exhibits anti- <i>Trypanosoma cruzi</i> Activity and Induces T Cell Cytokine Production. SSRN Electronic Journal.
Crossref
Crossref